TRCT
ERAS icon

Tower Research Capital (TRC)’s Erasca ERAS Stock Holding History

Tower Research Capital (TRC)’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$523K Buy
32,305
+25,421
+369% +$300K 0.01% 879
2025
Q4 		$25.6K Sell
6,884
-4,263
-38% -$12K ﹤0.01% 2915
2025
Q3 		$24.3K Sell
11,147
-10,386
-48% -$16.5K ﹤0.01% 3127
2025
Q2 		$27.3K Buy
21,533
+7,351
+52% +$9.84K ﹤0.01% 3474
2025
Q1 		$19.4K Sell
14,182
-9,141
-39% -$15.7K ﹤0.01% 2994
2024
Q4 		$58.5K Buy
23,323
+16,547
+244% +$45.4K ﹤0.01% 2459
2024
Q3 		$18.5K Sell
6,776
-5,873
-46% -$16.5K ﹤0.01% 3279
2024
Q2 		$29.9K Buy
12,649
+9,704
+330% +$20.9K ﹤0.01% 3492
2024
Q1 		$6.07K Sell
2,945
-15,195
-84% -$30.4K ﹤0.01% 4439
2023
Q4 		$38.6K Buy
18,140
+5,711
+46% +$12K ﹤0.01% 3291
2023
Q3 		$24.5K Buy
12,429
+8,705
+234% +$22.3K ﹤0.01% 3195
2023
Q2 		$10.3K Sell
3,724
-7,802
-68% -$22.2K ﹤0.01% 4140
2023
Q1 		$35K Buy
11,526
+10,626
+1,181% +$38.6K ﹤0.01% 2836
2022
Q4 		$4K Sell
900
-4,010
-82% -$27.2K ﹤0.01% 5000
2022
Q3 		$38K Sell
4,910
-1,039
-17% -$8.37K ﹤0.01% 3398
2022
Q2 		$33K Sell
5,949
-1,826
-23% -$12K ﹤0.01% 3272
2022
Q1 		$67K Buy
7,775
+6,040
+348% +$70K ﹤0.01% 2499
2021
Q4 		$27K Buy
1,735
+754
+77% +$12.9K ﹤0.01% 3340
2021
Q3 		$21K Buy
+981
New +$20.2K ﹤0.01% 3662

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Tower Research Capital (TRC)'s ERAS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Erasca (ERAS) stake by 369% in Q1 2026, buying an estimated $300K and bringing the position to 32,305 shares worth $523K. The position accounts for 0.01% of the portfolio, ranked #879.

Tower Research Capital (TRC) first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Tower Research Capital (TRC) held 32,305 shares of Erasca worth $523K as of Q1 2026.
  • Tower Research Capital (TRC) bought 25,421 Erasca shares in Q1 2026, an estimated $300K.
  • Erasca made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #879 holding.
  • Tower Research Capital (TRC) first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.